secwatch.observer — SEC 8-K summary
======================================

Issuer:     Azenta, Inc. (AZTA)
CIK:        0000933974
Form:       8-K
Filed at:   2025-12-29T23:59:59+00:00
Accession:  0001437749-25-038787
Event type: m_and_a
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Azenta sells B Medical Systems to related-party Thelema for $63M; close by Mar 31, 2026
--------------------------------------------------------------------------------

- Sale of B Medical Systems subsidiary to Thelema S.À R.L. for USD 63M; Thelema is majority-owned by Azenta VP & B Medical CEO Luc Provost.
- Thelema deposited $9M; remaining $54M due on or before Mar 31, 2026, subject to securing final residual financing.
- If financing condition not satisfied by Mar 31, 2026, Azenta retains $5M break-up fee and may terminate.
- Proceeds to be deployed to strengthen company and drive long-term shareholder value, per CEO John Marotta.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/933974/000143774925038787/0001437749-25-038787-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/933974/000143774925038787/azta20251226_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-038787

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer